2009
DOI: 10.1038/nn.2395
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia

Abstract: Cardiac arrest victims may experience transient brain hypoperfusion leading to delayed death of hippocampal CA1 neurons and cognitive impairment. We prevented this in adult rats by inhibiting the expression of transient receptor potential melastatin 7 (TRPM7), a transient receptor potential channel that is essential for embryonic development, is necessary for cell survival and trace ion homeostasis in vitro, and whose global deletion in mice is lethal. TRPM7 was suppressed in CA1 neurons by intrahippocampal in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
238
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 264 publications
(248 citation statements)
references
References 47 publications
7
238
2
Order By: Relevance
“…The activation of transient receptor potential melastatin (TRPM) channels, primarily the Ca 2+ -permeable TRPM2 (Lipski et al, 2006;Jia et al, 2011) and TRPM7 channels (Aarts et al, 2003;Sun et al, 2009), has been associated to oxidative stress, in addition to anoxic and ischemic cell death. Another key event during stroke is acidosis, caused by the decrease in the supply of oxygen to the brain, which leads to calcium influx, and failure of oxidative phosphorylation, with an increase in lactate production and the switch to glycolytic metabolism, with the final decrease in tissue pH (Xiong et al, 2004;Gu et al, 2010).…”
Section: Intracellular Calcium Overloadmentioning
confidence: 99%
“…The activation of transient receptor potential melastatin (TRPM) channels, primarily the Ca 2+ -permeable TRPM2 (Lipski et al, 2006;Jia et al, 2011) and TRPM7 channels (Aarts et al, 2003;Sun et al, 2009), has been associated to oxidative stress, in addition to anoxic and ischemic cell death. Another key event during stroke is acidosis, caused by the decrease in the supply of oxygen to the brain, which leads to calcium influx, and failure of oxidative phosphorylation, with an increase in lactate production and the switch to glycolytic metabolism, with the final decrease in tissue pH (Xiong et al, 2004;Gu et al, 2010).…”
Section: Intracellular Calcium Overloadmentioning
confidence: 99%
“…NR2A receptors in ischemic tolerance Y Terasaki et al receptor potential (TRP) channel and acid sensing ion channel can contribute to calcium accumulation that induces neuronal death (Sun et al, 2009;Xiong et al, 2004). Also, earlier study reported that TRPC6, one of the TRP channel subfamilies, was associated with CaMKIV-CREB-dependent gene transcription including BDNF .…”
Section: Nr2a Receptors In Ischemic Tolerancementioning
confidence: 99%
“…To ease personal and societal burden of stroke, continuous efforts have been directed towards searching for new therapeutic targets in stroke. This review provides a current view on one of the non-glutamate mechanisms of stroke that mediates through TRPM7 channels from a recent in vivo study [4] . A major event during cerebral ischemia is a concomitant massive release of the excitatory neurotransmitter glutamate, which results in intracellular calcium overload and eventual cell death [5] .…”
Section: Introductionmentioning
confidence: 99%
“…Because of the limitation of the glutamate mechanism and the unfavourable outcomes of AET trials, stroke researchers have been seeking for alternative, non-glutamate related therapeutic targets that cause ionic imbalance and cell death. Some of these channels include: acid-sensing ion channels [16,17] , transient receptor potential (TRP) channels [4,7,[18][19][20][21] , and hemichannels [22][23][24] , volume-regulated anion channels [25] , sodium-calcium exchangers [26,27] and non-selective cation channels [28] . Based on the recommendations from the Stroke Therapy Academic Industry Roundtable (STAIR) committee, it is important to validate the preclinical development in proof of concept starting with in vivo rodent models as experimental animal stroke models [29] .…”
Section: Introductionmentioning
confidence: 99%